Perez-Garcia, J. M., Batista, M. V., Cortez, P., Ruiz-Borrego, M., Cejalvo, J. M., de la Haba-Rodriguez, J., . . . Braga, S. (2023). Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial.
Citación estilo ChicagoPerez-Garcia, Jose Manuel, et al. Trastuzumab Deruxtecan in Patients With Central Nervous System Involvement From HER2-positive Breast Cancer: The DEBBRAH Trial. 2023.
Cita MLAPerez-Garcia, Jose Manuel, et al. Trastuzumab Deruxtecan in Patients With Central Nervous System Involvement From HER2-positive Breast Cancer: The DEBBRAH Trial. 2023.
Precaución: Estas citas no son 100% exactas.